+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

From
PEComa - Epidemiology Forecast - 2032 - Product Thumbnail Image

PEComa - Epidemiology Forecast - 2032

  • Report
  • July 2023
  • 58 Pages
  • Global
From
From
From
From
From
Aicardi Goutieres Syndrome - Epidemiology Forecast - 2032 - Product Thumbnail Image

Aicardi Goutieres Syndrome - Epidemiology Forecast - 2032

  • Report
  • August 2022
  • 62 Pages
  • Global
From
Liver Fibrosis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Liver Fibrosis - Epidemiology Forecast - 2032

  • Report
  • August 2022
  • 119 Pages
  • Global
From
Dystrophic Epidermolysis Bullosa - Epidemiology Forecast - 2032 - Product Thumbnail Image

Dystrophic Epidermolysis Bullosa - Epidemiology Forecast - 2032

  • Report
  • August 2022
  • 100 Pages
  • Global
From
From
From
From
From
From
From
From
Ischemia reperfusion injury - Epidemiology Forecast - 2032 - Product Thumbnail Image

Ischemia reperfusion injury - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Malignant Ascites - Epidemiology Forecast - 2032 - Product Thumbnail Image

Malignant Ascites - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more